Digoxin, beta-blockers have equivalent effects on heart rate in a-fib
Jul 23, 2024
Wearable device data could predict New York Heart Association functional class similarly to clinical measures and a six-minute walk test.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.
Fish oil beneficial for reducing risk for cardiovascular disease progression
May 22, 2024
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.
Physical activity time, step counts yield similar results
May 21, 2024
Similar benefits were seen for all-cause mortality and cardiovascular disease prevention.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
Acute cardiac event reported in 22.4 percent of seniors hospitalized with RSV
Apr 15, 2024
Risk for experiencing acute cardiac event higher for adults with underlying cardiovascular disease
ACC: Gamification plus financial incentives boost physical activity
Apr 11, 2024
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Salt substitution may reduce all-cause, cardiovascular mortality
Apr 08, 2024
A slight reduction was seen in major cardiovascular events; very low certainty of serious adverse events was reported.